This morning, Redknee reported its first quarter 2015 results. The company earned (U.S.) $2.01-million on revenue of $62.6-million, a topline that was up 4% over last year’s first quarter.
“In the first quarter of 2015, we continued to execute on our plan to improve revenue quality and ensure sustainable growth in order bookings, revenue and EBITDA,” said CEO Lucas Skoczkowski. “We have made progress towards our targets and are in line with our three-year objective, following the acquisition, for margin improvement. We see an opportunity to continue to improve our business in a disciplined way, while addressing the needs of our customers through the delivery of our unified software platform. We have advanced our position as the largest independent real-time converged monetization software provider for communications, and are leveraging our capabilities to address the long-term opportunity we see in the Internet-of-things market.”
Kew thinks the results were “mixed”, with EBITDA besting what he had modeled and support revenue and cash flow weaker than he expected. But the quarter left the analyst still bullish on Redknee’s prospects.
“Despite lower-than-expected cash flow, we are comfortable that management has sufficient liquidity (net cash of $54.1 million) to complete the integration, the restructuring and to significantly grow the overall business’ revenue, profitability and cash flow in F2016,” said Kew.
Canada’s labour market has softened sharply since the start of the year, with the unemployment rate reaching 7% in May,… [Read More]
Count RBC Capital Markets analyst Ken Herbert among the believers in MDA (MDA Stock Quote, Chart, News, Analysts, Financials TSX:MDA).… [Read More]
Roth Capital Markets analyst Suji Desilva said in a July 3 report that Netlist (Netlist Stock Quote, Chart, News, Analysts,… [Read More]
Research Capital analyst Andre Uddin is recommending Theratechnologies (Theratechnologies Stock Quote, Chart, News, Analysts, Financials NASDAQ:THTX) shareholders tender their shares… [Read More]
Haywood Capital Markets analyst Gianluca Tucci reiterated a “Buy” rating on KITS Eyecare (KITS Eyecare Stock Quote, Chart, News, Analysts,… [Read More]
Roth Capital Markets analyst Suji Desilva maintained a “Buy” rating and US$18.00 target on D-Wave Quantum (D-Wave Quantum Stock Quote,… [Read More]